Navigation Links
Injury Lawyers Release New Informational Graphic about the Alleged Link Between Victoza and Cancer
Date:9/6/2013

(PRWEB) September 06, 2013

Victoza (liraglutide) is a once-daily injection used to control blood sugar levels in type-2 diabetes patients. This medicine increases insulin while making the stomach feel full. The FDA approved this drug in January 2010 and it earned more than $2.3 billion in sales its first year on the market (i). Victoza, like all medicines, may cause side effects. According to the product’s website, the most common Victoza side effects were headache, nausea, and diarrhea. The manufacturer also warns that this drug may cause low blood sugar, pancreatitis, and cancer (ii). People who have suffered pancreatic cancer or thyroid cancer should talk to a personal injury attorney about their legal options.

As early as 2009 the FDA was concerned about the association between Victoza and cancer. The Agency reviewed the safety of the medicine in April 2009 and discovered twenty-nine cases of growths and tumors, including five cases of prostate cancer and five cases of thyroid cancer (iii). In June 2011, the FDA released new safety information on the drug highlighting the risk of thyroid cancer and acute pancreatitis with Victoza. The Agency also noted that this medicine is not recommended as the first choice for type-2 diabetes patients (iv). The most recent warning came in March 2013 when the FDA warned that the clinical trials had linked the drug to an “increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia.” Read the Drug Safety Communication here.

The Victoza infographic provides important information to type-2 diabetes patients, who are using the drug. Patients who have suffered Victoza side effects like cancer may be able to recover damages for medical bills, lost income, pain and suffering, and other injuries. d’Oliveira & Associates has been investigating these cases and the law firm is ready to answer any questions. They also work with some of the more experienced Victoza lawyers, who are handling these cases, and there are no legal fees unless you receive a settlement or award. Contact the law firm online or call 1-800-992-6878 for a free legal consultation.

(i) Novo Nordisk 2012 Annual Report.
webmedia.novonordisk.com/nncom/images/annual_report/2012/Novo-Nordisk-AR-2012-en.pdf
(ii) Product Website: Understanding Side Effects.
victoza.com/learn/usage-guidelines.aspx
(iii) Endocrine and Metabolic Drug Advisory Committee, April 2009.
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM148659.pdf%20FDA%20April%202009
(iv) Drug Safety Communication, March 2013.
fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm258826.htm

Read the full story at http://www.prweb.com/releases/2013/9/prweb11070331.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Why is traumatic brain injury increasing among the elderly?
3. Long-term neuropsychological impairment is common in acute lung injury survivors
4. Experts Offer Advice After Yankee Pitchers Trampoline Injury
5. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
6. Mild traumatic brain injury may contribute to brain network dysfunction
7. Injury-Linked Deaths Vary Widely Among States
8. Most occupational injury and illness costs are paid by the government and private payers
9. Diabetes drug could be a promising therapy for traumatic brain injury
10. Brain-Injury Recovery Varies Widely Among Children
11. Traumatic brain injury the focus of American Headache Society scientific conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
(Date:6/23/2016)... June 23, 2016 Research and ... Procedure Volumes: Global Analysis (United States, China, Japan, Brazil, ... report to their offering. ... for healthcare business planners, provides surgical procedure volume data ... trends with an in-depth analysis of growth drivers and ...
Breaking Medicine Technology: